Your session is about to expire
← Back to Search
Vaccination Program for Flu (Influential Trial)
N/A
Recruiting
Led By Suchitra Rao
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
- Admission to critical care sites or hematology-oncology services
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to investigate if a standardized vaccination program, developed with input from various stakeholders, can improve flu vaccination rates in hospitalized children in pediatric health systems across the US. The study will involve forming a
Who is the study for?
The INFLUENTIAL Trial is for hospitalized children at least 6 months old in participating US health systems, excluding those admitted to critical care or hematology-oncology services. It aims to see if a new program can improve flu vaccination rates.
What is being tested?
This trial tests whether a standardized inpatient influenza vaccination program, developed with input from various healthcare stakeholders and parents, can increase the number of hospitalized children getting flu shots.
What are the potential side effects?
Since the trial involves standard flu vaccinations, side effects may include soreness at the injection site, fever, muscle aches, and fatigue. These are typically mild and short-lived.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am admitted to a critical care or cancer treatment unit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Vaccine administration rate
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Standardized inpatient influenza vaccination programActive Control1 Intervention
Intervention A: The basic intervention is the inpatient influenza vaccination program, which will be comprised of the following core components: informatics and data analytic tools, evidenced-based education and communication, a multidisciplinary leadership team, and end-user engagement. Intervention B: The intensified intervention is the multifaceted influenza vaccination strategy (Intervention A) plus a learning collaborative with lead site facilitation during the trial period.
Group II: Existing inpatient influenza vaccination practicesActive Control1 Intervention
Usual care is defined as the inpatient influenza vaccination practices that currently exist at a given site.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,810 Previous Clinical Trials
2,898,100 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
408 Previous Clinical Trials
6,771,574 Total Patients Enrolled
Seattle Children's HospitalOTHER
310 Previous Clinical Trials
5,209,580 Total Patients Enrolled
Suchitra RaoPrincipal InvestigatorUniversity of Colorado, Children's Hospital Colorado